Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2002
10/31/2002CA2483507A1 Enzyme and snp marker for disease
10/31/2002CA2477842A1 Inhibition of jun kinase
10/31/2002CA2445627A1 Methods of using a hyaluronan receptor
10/31/2002CA2445216A1 Process for producing glycopeptide antibiotic by cultivating streptomyces hygroscopicus strains
10/31/2002CA2445197A1 T1r3 a novel taste receptor
10/31/2002CA2445179A1 Identification of essential genes of aspegillus fumigatus and methods of use
10/31/2002CA2445071A1 Oligonucleotide compositions and their use to induce differentiation of cells
10/31/2002CA2444907A1 Substantially pure glycopeptide antibiotics ac-98-1; ac-98-2; ac-98-3; ac-98-4 and ac-98-5
10/31/2002CA2444885A1 Methods and compositions for treating oral and esophageal lesions
10/31/2002CA2444883A1 Microprojection array having a beneficial agent containing coating
10/31/2002CA2444743A1 Viral vectors having reduced virulence
10/31/2002CA2444709A1 Compositions and methods to control bleeding
10/31/2002CA2444696A1 Polynucleotides and polypeptides associated with the nf-kb pathway
10/31/2002CA2444675A1 Secreted proteins
10/31/2002CA2444673A1 Glycopeptide antibiotics
10/31/2002CA2444626A1 Retrocyclins: antiviral and antimicrobial peptides
10/31/2002CA2444602A1 Anti-obesity polypeptides
10/31/2002CA2444594A1 Sprr1a and axonal regeneration
10/31/2002CA2444235A1 New polynucleotides and polypeptides of the ifn.alpha.-17 gene
10/31/2002CA2444098A1 Methods and compositions for the production of orthogonal trna-aminoacyl trna synthetase pairs
10/31/2002CA2444006A1 Expression of core-glycosylated hcv envelope proteins in yeast
10/31/2002CA2443946A1 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
10/31/2002CA2443935A1 Ppar-alpha-gamma ligands or agonists for the treatment of inflammation
10/31/2002CA2443913A1 Interleukin-1 homolog zil1a7
10/31/2002CA2443781A1 Core-glycosylated hcv envelope proteins
10/31/2002CA2443757A1 In vivo incorporation of unnatural amino acids
10/31/2002CA2443740A1 Constructs and methods for expression of recombinant hcv envelope proteins
10/31/2002CA2443373A1 New polynucleotides and polypeptides of the erythropoietin gene
10/31/2002CA2441540A1 Replikin peptides and uses thereof
10/31/2002CA2439693A1 Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof
10/31/2002CA2439690A1 Modified interferon alpha with reduced immunogenicity
10/31/2002CA2429351A1 A novel human g-protein coupled receptor, hgprbmy11, expressed highly in heart and variants thereof
10/30/2002EP1253201A2 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor
10/30/2002EP1252897A1 Drugs for gene therapy
10/30/2002EP1252895A1 Remedies for ophthalmic diseases
10/30/2002EP1252894A1 Use of agt and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions
10/30/2002EP1252883A1 Process for reducing partially or completely the symptoms associated with the histamin release within the human body
10/30/2002EP1252882A1 Process to increase the threshold tolerance of the sensitive skin
10/30/2002EP1252879A1 Stabilised enzyme compositions
10/30/2002EP1252519A2 Methods for detecting cancer of the central nervous system
10/30/2002EP1252333A2 Methods and materials relating to cd84-like polypeptides and polynucleotides
10/30/2002EP1252329A2 Hypocretin and hypocretin receptors in regulation of sleep and related disorders
10/30/2002EP1252325A1 Compositions and methods for inhibition of hiv-1 infection
10/30/2002EP1252323A2 Virus strains for the oncolytic treatment of cancer
10/30/2002EP1252322A2 Herpes virus strains for gene therapy
10/30/2002EP1252319A2 Combinatorial protein domains
10/30/2002EP1252313A2 Use of dendroaspin as a vehicle for non-dendroaspin domains
10/30/2002EP1252310A2 Mlp gene, nucleic acids, polypeptides and the utilization thereof
10/30/2002EP1252309A2 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1
10/30/2002EP1252308A2 Pharmaceutical compositions and methods of treatment based on vegf antisense oligonucleotides
10/30/2002EP1252306A1 Selective killing of cells by activation of double-stranded rna dependent protein kinase-pkr
10/30/2002EP1252303A2 Nucleic acids, proteins, and antibodies
10/30/2002EP1252302A2 Nucleic acids, proteins, and antibodies
10/30/2002EP1252300A2 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
10/30/2002EP1252299A2 Aspartyl proteases
10/30/2002EP1252298A2 Phosphodiesterases
10/30/2002EP1252297A1 Nucleic acids, proteins, and antibodies
10/30/2002EP1252290A1 Nucleic acids, proteins, and antibodies
10/30/2002EP1252289A2 Nucleic acids, proteins, and antibodies
10/30/2002EP1252189A2 Novel human nucleic acid molecules and polypeptides encoding cation channels
10/30/2002EP1252188A2 G-protein coupled receptors
10/30/2002EP1252187A2 Fil-1 theta dnas and polypeptides
10/30/2002EP1252186A2 Use of neuregulin-beta as an indicator and/or target
10/30/2002EP1252185A1 Nucleic acids, proteins, and antibodies
10/30/2002EP1252183A2 Method for reducing the immunogenicity of heterologous proteins by elimination of t-cell epitopes
10/30/2002EP1252182A1 PROTEINS COMPRISING CONSERVED REGIONS OF NEISSERIA MENINGITIDIS SURFACE ANTIGEN NhhA
10/30/2002EP1252181A2 Peptides with antibacterial activity
10/30/2002EP1252180A2 Virulence genes, proteins, and their use
10/30/2002EP1252179A2 High purity lipopeptides, lipopeptide micelles, processes for preparing same and pharmaceutical compositions containing them
10/30/2002EP1252178A1 Alpha-ketoamide inhibitors of hepatitis c virus ns3 protease
10/30/2002EP1252177A1 Ligand for vascular endothelial growth factor receptor
10/30/2002EP1252176A2 Nucleic acids, proteins, and antibodies
10/30/2002EP1252175A1 Antisense modulation of survivin expression
10/30/2002EP1252162A1 Alpha v integrin receptor antagonists
10/30/2002EP1252133A2 Pharmaceutical compounds
10/30/2002EP1251873A1 Antagonist of th-1 immuneresponse inducing cytokine for the treatment of autoimmune diseases
10/30/2002EP1251872A1 Compositions and methods for treating cell proliferation disorders
10/30/2002EP1251868A1 Combination therapy for the treatment of inflammatory and respiratory diseases
10/30/2002EP1251867A1 Nasal calcitonin formulations
10/30/2002EP1251866A1 Combination of temozolomide and pegylated interferon-alpha for treating cancer
10/30/2002EP1251865A1 Cyclic peptides as potent and selective melanocortin-4 receptor antagonists
10/30/2002EP1251864A1 Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release
10/30/2002EP1251863A1 22 human secreted proteins
10/30/2002EP1251862A1 Ophthalmic compositions for treating ocular hypertension
10/30/2002EP1251843A1 Compositions for delivery of a cortisol antagonist
10/30/2002EP1251840A2 Method for using potassium channel activation for delivering a medicant to an abnormal brain region and/or a malignant tumor
10/30/2002EP1251837A2 Compounds and methods for modulating cerebral amyloid angiopathy
10/30/2002EP1251832A2 Shell-and-core dosage form approaching zero-order drug release
10/30/2002EP1251827A2 Nasally administrable cyclic peptide compositions
10/30/2002EP1251750A1 Improved pediatric formula and methods for providing nutrition and improving tolerance
10/30/2002EP1152731A4 A skin care composition that mediates cell to cell communication
10/30/2002EP1135193B1 Agents provided for treating tumors, based on liposomes, and containing tamoxifen
10/30/2002EP1091774B1 Bone cement with antimicrobial peptides
10/30/2002EP1017412A4 Genes coding proteins for early liver development and their use in diagnosing and treating liver disease
10/30/2002EP1011634B1 Preparation of pharmaceutical compositions
10/30/2002EP0915707B1 Pharmaceutical composition comprising serum amyloid p component for prophylactic or therapeutic treatment of virus infections and a kit for detecting binding of compositions to virus components
10/30/2002EP0851763B1 Method and composition for enhanced parenteral nutrition
10/30/2002EP0835260B1 Antiproliferative protein from bacillus thuringiensis var. thuringiensis
10/30/2002EP0763061B1 Process and intermediate products for preparing cardiodilatin fragments, and highly purified cardiodilatin fragments
10/30/2002EP0726911B1 Treatment of hematologic disorders with a igf-1/igfbp-3 complex
1 ... 1967 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 ... 3163